Key Takeaways Expanding into high-growth segments and leveraging digital health and robotics is boosting recurring revenue, premium product adoption, and margin expansion. Operational efficiencies, divestitures, and strong US execution are driving improved cash flow and above-market share gains in core orthopedic categories.